🔎 Trials Near Me

Dachaigh › Myeloma iomaill › New Jersey › Clifton

Sgrùdaidhean clionaigeach Myeloma iomaill ann an Clifton, NJ

Tha 14 sgrùdaidhean airson Myeloma iomaill a’ lorg phàirtichean aig làraichean ann agus timcheall air Clifton (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

A’ fastadhÌre 1/2
  • Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT04973605

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

A’ fastadhÌre 4
  • Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05201781

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

A’ fastadhÌre 1
  • Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT03909412

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

A’ fastadhÌre 3
  • Hackensack Meridian Health, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07648264

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

A’ fastadhÌre 2
  • John Theurer Cancer Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT04661137

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

A’ fastadhÌre 1/2
  • Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06988488

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

A’ fastadhÌre 1
  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07075185

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

A’ fastadhÌre 1/2
  • Research Site, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT07681596

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

A’ fastadhÌre 1
  • Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT05651932

Mosaic Trial for Stem Cell Transplant Recipients

A’ fastadh
  • Hackensack Meridian Health, Nutley · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06960993

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

A’ fastadhÌre 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT06121843

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

A’ fastadhÌre 1
  • Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2025 · NCT05722418

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

A’ fastadhÌre 1/2
  • John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Sult 2025 · NCT05372354

Sgrùdaidhean Myeloma iomaill ann am bailtean eile

Sgrùdaidhean eile ann an Clifton

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.